The scientist’s investigation covers issues in Internal medicine, Women's Health Initiative, Gynecology, Hazard ratio and Breast cancer. Internal medicine and Endocrinology are commonly linked in his work. Jean Wactawski-Wende has researched Women's Health Initiative in several fields, including Randomized controlled trial, Proportional hazards model, Obstetrics, Physical therapy and Hormone replacement therapy.
Jean Wactawski-Wende interconnects Hysterectomy, Clinical trial, Cohort study, Placebo and Colorectal cancer in the investigation of issues within Gynecology. His Hazard ratio research is multidisciplinary, incorporating perspectives in Hip fracture and Surgery. His biological study spans a wide range of topics, including Body mass index, Absolute risk reduction and Oncology.
Jean Wactawski-Wende mainly focuses on Internal medicine, Women's Health Initiative, Hazard ratio, Gynecology and Endocrinology. Jean Wactawski-Wende works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Pancreatic cancer, as a part of the same area of interest. His work carried out in the field of Women's Health Initiative brings together such families of science as Hip fracture, Osteoporosis, Randomized controlled trial, Placebo and Physical therapy.
His Hazard ratio research incorporates themes from Diabetes mellitus and Surgery, Proportional hazards model. His Gynecology study combines topics in areas such as Medroxyprogesterone acetate, Estrogen, Obstetrics, Hormone therapy and Hormone replacement therapy. His work on Menstrual cycle, Luteinizing hormone, Vitamin D and neurology and Menopause as part of his general Endocrinology study is frequently connected to Context, thereby bridging the divide between different branches of science.
His scientific interests lie mostly in Internal medicine, Women's Health Initiative, Hazard ratio, Prospective cohort study and Body mass index. His research on Internal medicine often connects related areas such as Oncology. His Women's Health Initiative research integrates issues from Cancer, Hip fracture, Risk factor and Obstetrics.
In his study, which falls under the umbrella issue of Hazard ratio, Quartile is strongly linked to Stroke. His work deals with themes such as Obesity and Osteoporosis, which intersect with Body mass index. His research in Breast cancer focuses on subjects like Vasomotor, which are connected to Estrogen.
His primary areas of study are Internal medicine, Hazard ratio, Prospective cohort study, Women's Health Initiative and Body mass index. Jean Wactawski-Wende regularly ties together related areas like Oncology in his Internal medicine studies. His Hazard ratio study incorporates themes from Proportional hazards model, Incidence and Weight loss.
The concepts of his Prospective cohort study study are interwoven with issues in Cross-sectional study, Observational study, Endometrial cancer and Case-control study. His Women's Health Initiative research is multidisciplinary, relying on both Odds ratio, Physical therapy, Hip fracture, Insomnia and Breast cancer. His Body mass index study integrates concerns from other disciplines, such as Bone density, Cohort study and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson;Marian C. Limacher;Annlouise R. Assaf;Tamsen Bassford.
JAMA (2004)
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Sally A. Shumaker;Claudine Legault;Stephen R. Rapp;Leon Thal.
JAMA (2003)
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace.
The New England Journal of Medicine (2006)
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Jane A. Cauley;John Robbins;Zhao Chen;Steven R. Cummings.
JAMA (2003)
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Jean Wactawski-Wende;Jane Morley Kotchen;Garnet L. Anderson;Annlouise R. Assaf;Annlouise R. Assaf.
The New England Journal of Medicine (2006)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials
Jo Ann E. Manson;Rowan T. Chlebowski;Marcia L. Stefanick;Aaron K. Aragaki.
JAMA (2013)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung.
The New England Journal of Medicine (2011)
Estrogen plus progestin and colorectal cancer in postmenopausal women.
Rowan T. Chlebowski;Jean Wactawski-Wende;Cheryl Ritenbaugh;F. Allan Hubbell.
The New England Journal of Medicine (2004)
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women
Rowan T. Chlebowski;Garnet L. Anderson;Margery Gass;Dorothy S. Lane.
JAMA (2010)
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
Laufey Amundadottir;Peter Kraft;Rachael Z. Stolzenberg-Solomon;Charles S. Fuchs.
Nature Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard Medical School
UCLA Medical Center
Stanford University
University of Tennessee Health Science Center
The Ohio State University
Albert Einstein College of Medicine
Fred Hutchinson Cancer Research Center
University of Pittsburgh
University at Buffalo, State University of New York
Brigham and Women's Hospital
Complutense University of Madrid
ZF Friedrichshafen (Germany)
University of Leeds
McGill University
University of Sydney
Weizmann Institute of Science
Arizona State University
University of North Texas
University of Pennsylvania
Indian Institute of Science Education and Research, Bhopal
La Jolla Institute For Allergy & Immunology
United States Army Medical Research Institute of Infectious Diseases
University of Kansas
University of Alabama
Maastricht University
University of Wisconsin–Madison